Taha Azad Lab
@TahaAzad2
Followers
205
Following
223
Media
3
Statuses
82
Synthetic Biology For Translational Research
Sherbrooke, Quebec
Joined January 2018
Découvrez les travaux de recherche de l’équipe de @TahaAzad2 de @USherbrooke qui mettent en lumière une nouvelle approche qui repose sur l'ARN autoamplifiant (ARNaa) utilisée pour le traitement de certains cancers. 👉 https://t.co/vuzGOSRWNr
usherbrooke.ca
L’ingénierie moléculaire de l’ARN permet de concevoir ou de modifier des molécules d’ARN afin qu’elles ...
0
1
1
🔊Meet @TahaAzad2: He’s bringing his expertise in RNA therapeutics, oncolytic viruses, and biosensor development to @USherbrooke with support from D2R’s New Faculty Start-Up program 🔗Learn more: https://t.co/mfMhkKYGXQ
#ResearcherSpotlight #RNAtherapeutics #RNAResearch
0
1
8
Researchers have developed a novel approach to create tiny “mobile pharmacies” that can get inside tumours and dispense anti-cancer drugs. https://t.co/dKYZjcrpsd
1
6
23
The funding disparity for research trainees is even worse in Quebec, where students face greater financial struggles, as highlighted in @LP_LaPresse. https://t.co/ejbjXySrXQ read more: https://t.co/1lFS74pW2o
@FRQS1 @CIHR_IRSC
lapresse.ca
Ils sont considérés comme la crème de la relève scientifique… et vivent sous le seuil de la pauvreté. Appuyés par des chercheurs et des professeurs, des étudiants boursiers aux cycles supérieurs...
0
1
2
Celebrating the end of 2024 with our new publication led by @SuiyangLiao: we investigate the role of empty LNPs on transfection efficiency of mRNA- turns out they’re not just silent bystanders, and there’s a balance in how loaded you want your particles:
pubs.acs.org
When formulating mRNA into lipid nanoparticles (LNP), various copy numbers of mRNA are encapsulated, leading to a distribution of mRNA loading levels within the LNPs. It is unclear whether the mRNA...
3
6
35
Happy to share our new paper in Nature Biomedical Engineering! Special congratulations to the first author, Dr. Reza Rezaei, and our amazing collaborators. @Rezaeir75
@Tai_ImmunoLab
@TommyAlain3
https://t.co/JSyJdwLueb
https://t.co/tMYn6BExuT
nature.com
Nature Biomedical Engineering - The preferential susceptibility of oncolytic viruses to certain antibiotics can be exploited to accelerate the engineering of oncolytic viruses expressing transgenes...
3
9
26
Super excited to finally post about our RNA foundation model, led by our very own Ali Saberi (not on Twitter), with @genophoria , @AminMEmad , and @vram142. LoRNA-SH is splice-aware, takes as input the entire pre-mRNA, and models isoform diversity https://t.co/oPpYVYEEEP 1/n
biorxiv.org
Linking DNA sequence to genomic function remains one of the grand challenges in genetics and genomics. Here, we combine large-scale single-molecule transcriptome sequencing of diverse cancer cell...
3
27
125
Check out this exciting work by @genophoria and the team! Codon usage never disappoints!
Check out our latest research by @MNaghipourfar and others in our team on building language models of coding sequence. In this preprint, we introduce cdsFM, a suite of codon-resolution language models!👇 https://t.co/l1pFKi8PWx
0
2
7
Great opportunity!
📢 We have an opening for a postdoctoral researcher, working on statistical and ML models in (transcript)omics. If you're interested in gene regulation and its role in determining cell identity and function, check out our job posting:
0
0
1
What is the best strategy to quantify mRNA isoforms? Short-read RNA-seq to achieve high depth? Or long reads to get unambiguous read-isoform assignments? In our latest work with @genophoria, we show that what we really need is to combine both! (1/n)
biorxiv.org
Accurate quantification of transcript isoforms is crucial for understanding gene regulation, functional diversity, and cellular behavior. Existing RNA sequencing methods have significant limitations:...
3
49
160
The registration is open for the 12th Symposium of the RRCancer and MOH-Q! The meeting will be held in the Pierre-Péladeau amphitheatre at the CHUM on September 26th-27th, 2024 We invite you to register for the Symposium by clicking on the following link: https://t.co/w0WNiulqFz
0
2
6
Great lab ! Great opportunity!
We are looking for a postdoctoral fellow to join our lab at @BCCancer_GSC. Apply here: https://t.co/HIDwURUVYx. Read more about our work on our new lab website!
0
0
0
Congratulations Nika for your Vanier scholarship!
usherbrooke.ca
Félicitations à Nika Kooshki Zamani, qui fait partie des six personnes doctorantes de l’Université de ...
1
0
6
Shocked, saddened and so sorry to hear this news. 😢💔Even though we crossed paths only briefly, Wei made a huge impression on me. He is a super kind person and an exceptional scientist. Please consider donating to support his loved ones:
gofundme.com
Hi, My name is Xin, Wei's wife. It is with great sadness that we announce the p… Xin Fan needs your support for Provide financial support for kids' education
2
2
5
Je tiens à remercier les @FRQS1 de soutenir ma carrière en recherche. C’est un honneur de faire partie de la #communautéFRQ et de participer à l’avancement de la recherche au Québec et à l’étranger. Joignez votre voix à la mienne et propulsons ensemble la recherche !
1
2
12
Check out our new review on topical vaccination strategies led by @petyagpopova @sunnyc996 and @SuiyangLiao with @manishs_! Why aren't we administering more vaccines via our immune cell-rich skin?!
0
6
22
All cholangiocarcinoma patients deserve hope….for those with an FGF2R translocation/fusion, pemigatinib provides that hope.
We've responded to @ArndtVogel and Dr. Jennifer Knox's call and sent a letter to Ontario Health Ministers and MPs from C3's co-founder @auer_r 📢 Our voice NEEDS to be heard! Lives depend on it. Join together for cholangiocarcinoma 💚🤝 @ONThealth
0
8
26
So grateful to @cancersociety for funding and showcasing our research @USherbrooke on a therapeutic vaccine for triple negative breast cancer. It's a privilege to contribute to cancer research and strive for breakthroughs that can change lives.
Dr Tai’s work is a perfect example of what it takes to take on cancer: all of us. After all, nothing big gets solved by one person or one organization. And something that’s deeply true about cancer is that it’s big and endlessly complex. So here’s to taking it on together. 💛
0
3
21